Transjugular intrahepatic portosystemic shunt in liver transplant recipients

World Journal of Gastroenterology

Volumn 15, Issue 16, 2009, Pages 1999-2004

  Finkenstedt, Armin ^a   Graziadei, Ivo W ^a   Nachbaur, Karin ^a   Jaschke, Werner ^a   Mark, Walter ^a   Margreiter, Raimund ^a   Vogel, Wolfgang ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Ascites; Immunosuppression; Liver transplantation; Portal hypertension; Variceal bleeding

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES; BRAIN DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COLON HEMORRHAGE; DISEASE ASSOCIATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; GRAFT FAILURE; GRAFT RECIPIENT; HEPATITIS C; HUMAN; HYDROTHORAX; KIDNEY FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG HEMORRHAGE; MALE; PORTAL VEIN THROMBOSIS; PRESSURE GRADIENT; RECURRENT INFECTION; RETRANSPLANTATION; SCORING SYSTEM; SURVIVAL TIME; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT FAILURE; TREATMENT RESPONSE;

ADULT; AGED; FEMALE; HUMANS; HYPERTENSION, PORTAL; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PRESSURE; RETROSPECTIVE STUDIES;

EID: 67651151355     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.1999     Document Type: Article

References (30)

1. Rösch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology 1969; 92: 1112-1114
2. Wettstein M, Lüthen R, Cohnen M, von Wrisberg F, Mödder U, Häussinger D. [Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome] Zentralbl Chir 2005; 130: 246-249
3. Rössle M, Deibert P, Haag K, Ochs A, Olschewski M, Siegerstetter V, Hauenstein KH, Geiger R, Stiepak C, Keller W, Blum HE. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997; 349: 1043-1049
4. Rössle M, Ochs A, Gülberg V, Siegerstetter V, Holl J, Deibert P, Olschewski M, Reiser M, Gerbes AL. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342: 1701-1707
5. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP 3rd, Shiffman ML, Cole PE, Tisnado J, Simmons S. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997; 126: 849-857
6. Rössle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 1998; 18: 73-89
7. Ochs A, Rössle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, Huonker M, Langer M, Blum HE. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332: 1192-1197
8. Cirera I, Navasa M, Rimola A, García-Pagán JC, Grande L, Garcia-Valdecasas JC, Fuster J, Bosch J, Rodes J. Ascites after liver transplantation. Liver Transpl 2000; 6: 157-162
9. Adetiloye VA, John PR. Intervention for pleural effusions and ascites following liver transplantation. Pediatr Radiol 1998; 28: 539-543
10. Mabrut JY, de la Roche E, Adham M, Ducerf C, Baulieux J. [Peritoneovenous diversion using the LeVeen shunt in the treatment of refractory ascites after liver transplantation] Ann Chir 1998; 52: 612-617
11. Lerut JP, Goffette P, Molle G, Roggen FM, Puttemans T, Brenard R, Morelli MC, Wallemacq P, Van Beers B, Laterre PF. Transjugular intrahepatic portosystemic shunt after adult liver transplantation: experience in eight patients. Transplantation 1999; 68: 379-384
12. Van Ha TG, Funaki BS, Ehrhardt J, Lorenz J, Cronin D, Millis JM, Leef J. Transjugular intrahepatic portosystemic shunt placement in liver transplant recipients: experiences with pediatric and adult patients. AJR Am J Roentgenol 2005; 184: 920-925
13. Amesur NB, Zajko AB, Orons PD, Sammon JK, Casavilla FA. Transjugular intrahepatic portosystemic shunt in patients who have undergone liver transplantation. J Vasc Interv Radiol 1999; 10: 569-573
14. Abouljoud M, Yoshida A, Kim D, Jerius J, Arenas J, Raoufi M, Brown K, Moonka D. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation. Transplant Proc 2005; 37: 1248-1250
15. Kim JJ, Dasika NL, Yu E, Fontana RJ. Transjugular intrahepatic portosystemic shunts in liver transplant recipients. Liver Int 2008; 28: 240-248
16. LaBerge JM, Somberg KA, Lake JR, Gordon RL, Kerlan RK Jr, Ascher NL, Roberts JP, Simor MM, Doherty CA, Hahn J. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995; 108: 1143-1151
17. Russo MW, Jacques PF, Mauro M, Odell P, Brown RS Jr. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt. Liver Transpl 2002; 8: 271-277
18. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871
19. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470
20. Berenguer M, López-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol 2001; 35: 666-678
21. Neumann UP, Neuhaus P. Course and treatment of recurrent Hepatitis C after liver transplantation. Minerva Gastroenterol Dietol 2004; 50: 61-66
22. Berenguer M, Prieto M, Rayón JM, Mora J, Pastor M, Ortiz V, Carrasco D, San Juan F, Burgueño MD, Mir J, Berenguer J. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 2000; 32: 852-858
23. Gane E. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients. Liver Transpl 2003; 9: S28-S34
24. Lowes JR, Hubscher SG, Neuberger JM. Chronic rejection of the liver allograft. Gastroenterol Clin North Am 1993; 22: 401-420
25. Freese DK, Snover DC, Sharp HL, Gross CR, Savick SK, Payne WD. Chronic rejection after liver transplantation: a study of clinical, histopathological and immunological features. Hepatology 1991; 13: 882-891
26. van Hoek B, Wiesner RH, Krom RA, Ludwig J, Moore SB. Severe ductopenic rejection following liver transplantation: incidence, time of onset, risk factors, treatment, and outcome. Semin Liver Dis 1992; 12: 41-50
27. Sher LS, Cosenza CA, Michel J, Makowka L, Miller CM, Schwartz ME, Busuttil R, McDiarmid S, Burdick JF, Klein AS, Esquivel C, Klintmalm G, Levy M, Roberts JP, Lake JR, Kalayoglu M, D'Alessandro AM, Gordon RD, Stieber AC, Shaw BW Jr, Thistlethwaite JR, Whittington P, Wiesner RH, Porayko M, Cosimi AB. Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group. Transplantation 1997; 64: 258-263
28. Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoli F, Boccia S, Colloredo-Mels G, Corigliano P, Fornaciari G, Marenco G, Pistarà R, Salvagnini M, Sangiovanni A. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 2001; 33: 41-48
29. Fernández J, Navasa M, Gómez J, Colmenero J, Vila J, Arroyo V, Rodés J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140-148
30. Schmitz V, Laudi S, Moeckel F, Puhl G, Stockmann M, Tran ZV, Kahl A, Neumann U, Neuhaus P. Chronic renal dysfunction following liver transplantation. Clin Transplant 2008; 22: 333-340